References
Poplawska-Domaszewicz K, Florczak-Wyspianska J, Kozubski W, Michalak S (2018) Paraneoplastic movement disorders. Rev Neurosci 29(7):745–755
Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP (2018) Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain 141(1):13–36
Mohammad SS, Ramanathan S, Brilot F, Dale RC (2013) Autoantibody-associated movement disorders. Neuropediatrics. 44(6):336–345
Tani T, Piao Y, Mori S, Ishihara N, Tanaka K, Wakabayashi K, Takahashi H (2000) Chorea resulting from paraneoplastic striatal encephalitis. J Neurol Neurosurg Psychiatry 69(4):512–515
Vernino S, Tuite P, Adler CH, Meschia JF, Boeve BF, Boasberg P, Parisi JE, Lennon VA (2002) Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 51(5):625–630
Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG (2010) Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol 69(10):997–1007
Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Carlson NG (2015) Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. PLoS One 10(4):e0123446
Vigliani MC, Honnorat J, Antoine JC, Vitaliani R, Giometto B, Psimaras D et al (2011) Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience. J Neurol 258(11):2058–2068
Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V et al (2009) Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 80(4):412–416
Dericioglu N, Gocmen R, Tan E (2018) Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2/CRMP-5 antibodies in a patient with small cell lung cancer. Clin Neurol Neurosurg 170:117–119
Aliprandi A, Terruzzi A, Rigamonti A, Bazzigaluppi E, Tremolizzo L, Ferrarese C, Salmaggi A (2015) Paraneoplastic cerebellar degeneration with anti-CV2/CRMP5 antibodies and prostate adenocarcinoma. Neurol Sci 36(8):1501–1503
Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49(2):146–154
Tada S, Furuta M, Fukada K, Hirozawa D, Matsui M, Aoike F, Okuno T, Sawada JI, Mochizuki H, Hazama T (2016) Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia. J Neurol Neurosurg Psychiatry 87(8):907–910
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The patient provided written informed consent for case description.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Supplementary Figure 1
Selected cervical and thoracic spine MRI images of the patient at disease diagnosis. A: T2-weighted sagittal image of cervical spine without intramedullary lesions. B: T1-weighted sagittal image with Gd of cervical spine without Gd-enhancing lesions. C. A: T2-weighted sagittal image of thoracic spine without intramedulallry lesions. Of note, severe scoliosis of thoracic spine is evident. (PNG 681 kb).
Rights and permissions
About this article
Cite this article
Vakrakou, A., Constantinides, V.C., Velonakis, G. et al. Paraneoplastic basal ganglia encephalitis associated with anti-CV2/CRMP-5 and anti-Yo antibodies in a patient with non-small-cell lung cancer. Neurol Sci 41, 2649–2651 (2020). https://doi.org/10.1007/s10072-020-04399-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04399-1